Treatment decisions for MRSA in patients with cystic fibrosis (CF): when is enough, enough? | Thorax

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article info

Editorial

Treatment decisions for MRSA in patients with cystic fibrosis (CF): when is enough, enough?

Free

Authors

Scott C Bell QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, Queensland, Australia PubMed articles Google scholar articles
Patrick A Flume Departments of Medicine and Pediatrics, Medical University of South Carolina, Charleston, South Carolina, USA PubMed articles Google scholar articles

Correspondence to Dr Scott C Bell, Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane 4032, Queensland, Australia; scott.bell{at}health.qld.gov.au

Citation

Bell SC, Flume PA

Treatment decisions for MRSA in patients with cystic fibrosis (CF): when is enough, enough?

Thorax 2017;72:297-299.

Publication history

First published January 11, 2017.

Online issue publication

September 01, 2022

Article Versions

Previous version (18 March 2017).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/